Training in Evidence-based Treatments in Psycho-Oncology

This study aims to train therapists to provide personalized behavioral therapies to cancer patients and their caregivers who are experiencing distress. These therapies, like Cognitive Behavioral Therapy (CBT) or Mindfulness-Based Stress Reduction (MBSR), are chosen based on your specific needs. To join, you must be an adult (18+) receiving cancer care at MGH Cancer Center and report elevated levels of distress related to your illness or treatment. The study will measure how acceptable these evidence-based treatments are to patients and caregivers over approximately 26 weeks. The study is currently recruiting about 115 participants.

Study design: This is a single-arm study, meaning all participants receive the intervention, and aims to enroll 115 participants.
What's involved: You would undergo screening, complete surveys and questionnaires, and participate in virtual or in-person therapy sessions for about 26 weeks.
Compensation: Not stated in the trial record.
Follow-up: The primary endpoint, treatment acceptability, is measured for up to 26 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Training in Evidence-based Treatments in Psycho-Oncology

Recruiting

NAAges 18+InterventionalSupportive care

Massachusetts General Hospital

~115 participants

Updated 2026-06-15 on ClinicalTrials.gov

What's tested:Individualized Evidence-Based Therapy in Cancer (Patients and Caregivers)Training in Individualized Evidence-Based Therapy in Cancer (Therapists)

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Evidence-Based Treatment Acceptability

Measured over up to 26 weeks

Conditions

Distress, Emotional

Depression, Anxiety

Fatigue

Pain

Insomnia

Where it's being run

1 sites across 1 states

Massachusetts1

Study leadership

Jamie Jacobs, Ph.D · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

Jamie Jacobs, Ph.D

[email protected]

617-643-1777

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Adults \> 18 years of age.

Currently receiving oncology treatment/care at the MGH Cancer Center, including active treatment and/or surveillance.

Reports elevated levels of distress on the National Comprehensive Cancer Network (NCCN) Distress Thermometer \> 3.

Reports distress or presenting problem is related to patients' illness and/or treatment (e.g., cancer treatment).

Has a clinical presentation that matches an evidence-based treatment (e.g., CBT-I for insomnia/sleep disturbance) for cancer-related distress per therapist and supervising therapist discretion.

Located in the state of Massachusetts for the duration of sessions.

Adults \> 18 years of age

Currently caring for someone receiving oncology treatment/care at the MGH Cancer Center, including active treatment and/or surveillance

Reports elevated levels of distress on the National Comprehensive Cancer Network (NCCN) Distress Thermometer \> 3

Reports distress or presenting problem is related to caregiving

Has a clinical presentation that matches an evidence-based treatment (e.g., CBT-I for insomnia/sleep disturbance) for caregiving-related distress per therapist and supervising therapist discretion

Located in the state of Massachusetts for the duration of sessions

Current appointment as a clinical psychology fellow or psychiatry resident at the Massachusetts General Hospital or equivalent designation.

Exclusion

Has uncontrolled psychosis, active suicidal ideation, or psychiatric hospitalization within the past year (assessed through EHR review and screening session using the QuickSCID-5), indicating the need for tailored treatment referral to specialty mental healthcare outside of psycho-oncology or to a higher level of care such as an intensive outpatient program (IOP).

Has a cognitive impairment that prohibits participation in the study (assessed through EHR review and screening session).

Currently participating in group or individual evidence-based psychotherapy treatment or other psychosocial intervention trial.

Has an alcohol or substance dependence (other than nicotine dependence) in the past 8 weeks (assessed through EHR review and screening session using the QuickSCID-5), indicating the need for tailored treatment referral to specialty mental healthcare outside of psycho-oncology or to a higher level of care such as an intensive outpatient program (IOP).

Obtained licensure as a clinical psychologist in any state.

What this trial measures

Evidence-Based Treatment Acceptabilityup to 26 weeks
Patients and caregivers will report acceptability of evidence-based treatment delivered by therapists receiving training in psycho-oncology on the Client Satisfaction Questionnaire (acceptability criteria: \>75% of patients score ≥ the CSQ's midpoint \[3\]). Defined by the Client Satisfaction Questionnaire (CSQ), a 3-item, validated measure to assess satisfaction with services provided to the participant. Each item is answered on a scale of 1-4 with a total score range of 3-12. Acceptability criteria is \> 75% of participants with a score ≥ the CSQ's midpoint.

Trialytics